ArticleCell2024
Preclinical proof of principle for orally delivered Th17 antagonist miniproteins.
Stephanie Berger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this papercites it
ArticleCell2024
Stephanie Berger et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.